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Nowadays, acute respiratory distress syndrome (ARDS) remains life threatening despite new strategies 
in mechanical ventilations [1,2,3] and, to limit ventilation induced lung injury (VILI) [4], protective 
ventilation is recommended for patients with ARDS. Protective ventilation is characterized by low 
tidal volumes (6ml/kg) and a plateau pressure below 30 cmH2O. However, such a ventilation can 
induce hypercapnic acidosis and be deleterious for the right ventricle by increasing pulmonary 
hypertension [5,6]. Therefore, hypercapnic acidosis must be strictly controlled by eliminating the 
excess CO2. This control can be done in intensive care units (ICU) using an extracorporeal CO2 
removal device (ECCO2RD, see Figure 1). 
 
The aim of the present study is to build a mathematical model of the respiratory system connected to 
an ECCO2RD to optimize the gas exchanges efficiency. The model must be simple enough to provide 
rapid solutions and to estimate specific parameters from available clinical data. But it also must be 
complex enough to be able to simulate the respiratory system when protective ventilation is used and 
when this system is assisted by an ECCO2RD.  
 
We will first describe the mathematical model. Then experiments carried out on pigs will be used to 
validate the approach and the agreement between the model and experimental data will be discussed.  
 
2. Materials and Methods 
In this study, the respiratory system linked to an ECCO2RD is reduced to a small number of 
"compartments" (lumped parameter model). We consider two compartments for the respiratory 
system: the lung and the tissues. In addition, a third compartment is added to model the ECCO2RD 
(see Figure 1). 
Our mathematical model of pulmonary gas exchanges and tissues gas exchanges is based on the work 
of Batzel et al. [7]. Transport delays in the blood circulation are taken into account and the hypothesis 
of equilibrium between alveoli and pulmonary capillaries concentrations is taken for granted. To 
include pulmonary insufficiencies in our model, additional parameters and additional equations must 
be considered. Some authors describe pulmonary gas exchanges abnormalities by dividing the lung 
into 2 compartments to model ventilation/perfusion mismatch [8,9]. Since the identification of the 
parameters of these two compartments is not easy (and even impossible in our case with the available 
experimental data), we will use a simpler approach. To describe the global quality of gas exchanges 
and to allow the modeling of lung injuries in a simple way, we will consider a pulmonary shunt, 
characterized by the fraction fS of blood flow which does not participate in the gas exchange, and the 
dead volume VD. 
The ECCO2RD can be considered as a second lung compartment which removes the CO2 from the 
blood and which also oxygenates the blood. The device takes a fraction of the systemic blood flow in 
the inferior vena cava and rejects the decarboxylated blood in the right atrium (see Figure 1). The 
dynamics of gas exchanges along the synthetic membrane is different from that in the lung. The 
exchange surface in the ECCO2RD is indeed much smaller than in the lungs and the hypothesis of 
equilibrium between the gas and the blood is not valid. Therefore, the diffusion of O2 and CO2 
between the gas and the blood across the synthetic membrane has to be modeled [10]. In this study, we 
consider a 1-D model, with air and gas flows in opposite directions (see for instance [11]).  
	
Figure 1. (A) Patient assisted by an ECCO2RD (Figure adapted from M.J. Murray and D.J. Cook [12]). The 
abbreviations RA and IVC mean respectively the right atrium and the inferior vena cava. (B) The three 
compartments of our model. The symbols fS and fd are respectively the pulmonary shunt fraction and the fraction 
of cardiac blood flow (QC) which crosses the ECCO2RD. The symbols Ca,i , Cv,i , Cd,i , Crv,i and Cl,i denote 
respectively the blood concentrations for component i in arteries, in veins, after the ECCO2RD, in the right 
ventricule and in the lung. 
 
The blood chemistry model proposed by Batzel et al. [7] is not valid in our case since the CO2 partial 
pressure can vary very significantly, especially when protective ventilation is used and when the 
ECCO2RD is switched on. These variations can influence the pH in blood plasma, which then 
modifies the O2 haemoglobin saturation curve. To take this into account, we use the relation between 
O2 concentration and O2 partial pressure following the work of Grodins et al. [13]. The relations 
between CO2 concentration, pH in plasma and CO2 partial pressure are based on the work of Trueb et 
al. [14]. 
 
To validate our model, experiments were carried out on 6 pigs, with the approval of the Ethics 
Committee of the Medical Faculty of the University of Liège. At the beginning of the experiment, after 
the anesthesia and the intubation of the pig, and a 30 min stabilization period, all the parameters were 
measured (cardiac blood flow, venous and arterial blood concentrations like O2, CO2 and H+ and 
parameters fixed by the ventilator) defining our baseline situation. From this baseline situation, severe 
hypercapnic acidosis was induced thanks to about 40 min of protective ventilation with very low tidal 
volumes. Then the extracorporeal CO2 removal device (a PALP Maquet® device is used) was switched 
on to decarboxylate the blood. The gas flow through the device was set to 10 l/min, while the blood 
flow was progressively increased from 200 ml/min, to 400 ml/min and finally to 600 ml/min. Each flow 
was kept constant for about 45 min. Then the decarboxylation process was stopped by fixing the gas 
flow to 0 ml/min (note that in order to avoid clots formation, the blood flow was kept at 200 ml/min). 
The cardiac blood flow was measured with thermodilution technique (PiCCO®, Pulsion, Germany) and 
also with an admittance pressure-volume catheter (Transonic, USA). Tidal volume, PEEP, FI,O2, 
respiratory frequency and driving pressure were fixed by the ventilator (Engström Carestation®). 
Arterial and venous blood samples were analyzed with a RapidPoint500® (Siemens, Germany) during 
baseline situation, after protective ventilation and during the CO2 removal procedure. Additional blood 
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The two parameters fS and VD, which allow characterizing the quality of gas exchanges, are fitted with 
experimental data. More details on this fitting will be discussed later on. Finally the CO2 production 
(MRCO2) by metabolism can be estimated by:  
  MRCO2 = Qc (Cv,CO2 – Ca,CO2),                       (6) 
where QC is the cardiac output, while Cv,CO2 and Ca,CO2 are the total venous and arterial CO2 
concentrations respectively. The O2 consumption (MRO2) can be determined similarly. These estimated 
values are kept constant during the baseline situation and during protective ventilation. However, when 
the ECCO2RD is switched on, the temperature decreases significantly (for all pigs, the temperature falls 
by about 4°C between the beginning and the end of the extracorporeal CO2 removal therapy) and MRO2 
and MRCO2 vary with the temperature. Therefore, MRCO2 and MRO2 decrease with the temperature in our 
simulations according to a rate of 6 •10-3 l/min/°C, which was experimentally evaluated. The other 
parameters of the mathematical model are mainly direct experimental measurements (cardiac blood 




Our results are similar for the 6 pigs. The numerical simulation of the model allows determining the 
O2 and CO2 partial pressures (PO2 and PCO2) evolutions at different locations of the respiratory 
system and for the different stages of the experimental procedure presented before. Our results are 




Figure 2: Time evolutions of O2 and CO2 partial pressures. The vertical lines indicate the beginning of the 
different phases of the experiment (PV: start of protective ventilation; ECCO2RD 200: flow of 200 ml/min in the 
CO2 removal device; ECCO2RD 400: flow of 400 ml/min in the CO2 removal device; ECCO2RD 600: flow of 
600 ml/min in the CO2 removal device and ECCO2RD Stop: the ECCO2RD is switched off). The solid line 
shows the O2 partial pressure evolution in veins and the circles show the corresponding experimental data. The 
dashed lines show the CO2 partial pressures evolutions in arteries and in veins. The crosses show the 
corresponding experimental data. 
 
4. Discussion and Conclusions 
Figure 2 shows good agreement between the model predictions and the experimental data. It is worth 
stressing that several different experimental situations such as a protective ventilation and an 
extracorporeal CO2 removal therapy with different blood flows across the device are considered with a 
unique model and that the time window of the simulations is also rather large. This thus provides a 
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strong validation of our approach. Several additional remarks can be done about these results. First, 
one can observe in Figure 2 the large increase of CO2 partial pressure in veins and in arteries when the 
protective ventilation is introduced. The figure also shows clearly that the system hasn’t reached a 
stabilized state after 40 min of protective ventilation. For this reason, it is a delicate process to 
determine the values of the two parameters fS and VD during this state because of the unsteady 
behaviour. The parameter fS is assumed to be constant for the whole simulation, but the same 
hypothesis cannot be introduced for the dead volume VD. Indeed, when the protective ventilation is 
introduced, the tidal volume is reduced, which is directly related to the dead volume 
VD.  Consequently, as a first step, the two parameters fS and VD are estimated during steady baseline 
situation. Then, parameter VD must be reassessed to fit experimental data during the protective 
ventilation and the obtained value is kept for the rest of the simulation.  It is interesting to stress that 
very large values of VD are found: 70% of the tidal volume during baseline situation and 85% of the 
tidal volume during protective ventilation. The origin of these large values is the dead volume of the 
ventilator which is quite large due to additional pipes and sensors for gas analysis. 
 
In this work, we have built a mathematical model of the respiratory system assisted by an 
extracorporeal CO2 removal device (ECCO2RD) and the predictions of the model are in good 
agreement with experimental data corresponding to a rather complex situation (time evolution during 
protective ventilation and for different settings of the ECCO2RD). The model requires a detailed 
description of blood chemistry, a precise model of gas exchanges in the ECCO2RD and a careful 
evaluation of the dead volume. It was also necessary to take into account the temperature dependence 
of metabolism and a detailed non-stationary modeling was also needed (e.g. transport delays in the 
blood circulation are taken into account).  
 
In future works, the model will also be used to predict the behavior of patients with pulmonary 
insufficiencies for which protective ventilation and an ECCO2RD are used. We hope that our model 
will help understanding the mechanisms of assisted ventilation and provide clinicians with a new tool 
allowing the optimization of care in ICU. 
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